2-hydroxyphytanic acid has been researched along with pristanic acid in 2 studies
Studies (2-hydroxyphytanic acid) | Trials (2-hydroxyphytanic acid) | Recent Studies (post-2010) (2-hydroxyphytanic acid) | Studies (pristanic acid) | Trials (pristanic acid) | Recent Studies (post-2010) (pristanic acid) |
---|---|---|---|---|---|
8 | 0 | 1 | 103 | 2 | 17 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jakobs, C; Kok, RM; Poll-The, BT; Schor, DS; ten Brink, HJ; Wanders, RJ | 1 |
Jakobs, C; Jansen, GA; Schor, DS; Verhoeven, NM; Wanders, RJ | 1 |
2 other study(ies) available for 2-hydroxyphytanic acid and pristanic acid
Article | Year |
---|---|
Phytanic acid alpha-oxidation: accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders.
Topics: Adolescent; Adult; Carbon Radioisotopes; Child; Child, Preschool; Fatty Acids; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infant, Newborn; Middle Aged; Phytanic Acid; Refsum Disease | 1992 |
Phytanic acid alpha-oxidation: decarboxylation of 2-hydroxyphytanoyl-CoA to pristanic acid in human liver.
Topics: Biomarkers; Cell Fractionation; Coenzyme A; Decarboxylation; Fatty Acids; Humans; Liver; Microbodies; Microsomes; NAD; Phytanic Acid; Zellweger Syndrome | 1997 |